To expand treatment options for future stroke patients, Michael Stechison, M.D., Ph.D. and Gwinnett Medical Center (GMC) have been awarded a research grant from the National Institutes of Health in partnership with Johns Hopkins University. The study, Minimally Invasive Surgery + rt-PA for Intracerebral Hemorrhage (ICH) Evacuation (or MISTIE), explores the use of tPA (a thrombolytic or clot-busting drug) delivered via a catheter placed using CT guidance.
Through the study, physicians will investigate clot-size reduction related to improved outcomes. Based on Dr. Stechison’s leadership, GMC is one of only 60 participants internationally and the only participant in Georgia. As a grant sub-recipient, Dr. Stechison and GMC will work closely with Johns Hopkins University. He is GMC’s director of neuroscience services.
“This recognition from NIH and Johns Hopkins further solidifies GMC as a first-rate research institution,” said Phil Wolfe, president and CEO of GMC. “Further, the research efforts represent our commitment to better health outcomes, and provide the community with a range of options all while supporting our leading physicians.”
“As a physician, it is important to efficiently use medical resources and this study represents a contribution to this end goal,” said Dr. Stechison, a fellow of The American College of Surgeons. “This work is a contribution for better living for patients who have experienced an intracerebral stroke,” the medical director of The Brain and Spine Institute continued.
An intracerebral hemorrhage can be caused by abnormalities of the blood vessels, high blood pressure, deposits along blood vessels or traumatic brain injury.